Top

Journal of Diabetes & Metabolic Disorders

Published in:

01-06-2021 | Affective Disorder | Research article

Distress and depression among patients with diabetes mellitus: prevalence and associated factors: a cross‐sectional study

Authors: Mahtab Niroomand, Sepideh Babaniamansour, Ehsan Aliniagerdroudbari, Ali Golshaian, Azadeh Mazaheri Meibodi, Abdorrahim Absalan

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2021

Abstract

Purpose

This study aimed to validate the internal consistency of the Persian version of the diabetes distress scale-17 (DDS-17) and to investigate the prevalence of diabetes distress (DD), depression, and possible relevant factors.

Methods

This was a cross-sectional study on 820 diabetes patients (62.4 % females) in Tehran, Iran between January and June 2017. The Ethics Committee of Shahid Beheshti University of Medical Sciences approved the protocol. Patients filled out a demographic and health survey, DDS-17, the Beck Depression Inventory Second Edition (BDI-II) and the Summary of Diabetes Self–Care Activities Measure (SDSCA). DDS-17 consist of emotional burden, and physician, regimen, and interpersonal related distress. The correlation between DDS subscales and association between DDS and BDI-II or SDSCA scores were assessed using SPSS.

Results

The mean age was 58.91 ± 12.35 years. Majority of patients had high DD (37.2 %) and severe depression (38.7 %). The general and specific diets got the highest score in six SDSCA subscales. The Persian version of DDS-17 had excellent internal consistency with Cronbach’s alpha coefficient of 0.924. The DDS score had significant relationship with socioeconomic level (p < .001), type of DM (p < .001), type of treatment (p < .001), glycemic control status (p < .001), complication (p < .001) and depression level (p < .001). The level of hemoglobin A1c was the most useful predictor of DDS score (p < .001).

Conclusions

High prevalence of depression and distress in patient with diabetes calls for greater emphasizes on the importance of enhanced physicians and patients’ knowledge in these areas.

Safari-Faramani R, Rajati F, Tavakol K, Hamzeh B, Pasdar Y, Moradinazar M, et al. Prevalence, awareness, treatment, control, and the associated factors of diabetes in an Iranian Kurdish population. J Diabetes Res. 2019;2019:5869206. https://doi.org/10.1155/2019/5869206.CrossRefPubMedPubMedCentral

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157. https://doi.org/10.1016/j.diabres.2019.107843.

Moosaie F, Davatgari R, Dehghani Firouzabadi F, Esteghamati S, Deravi N, Meysamie A, et al. Lp(a) and Apo-lipoproteins as predictors for diabetic retinopathy and its severity in patients with type 2 diabetes: A case-cohort study. Can J Diabetes. 2020;44. https://doi.org/10.1016/j.jcjd.2020.01.007.

Moosaie F, Dehghani Firouzabadi F, Abouhamzeh K, Esteghamati S, Meysamie A, Rabizadeh S, et al. Lp(a) and Apo-lipoproteins as predictors for micro-and macrovascular complications of diabetes: A case-cohort study. Nutr Metab Cardiovasc Dis. 2020;30. https://doi.org/10.1016/j.numecd.2020.05.011.

Babaniamansour S, Aliniagerdroudbari E, Afrakhteh M, Hosseinpanah F, Farzaneh F, Niroomand M. Can fasting plasma glucose replace oral glucose tolerance test for diagnosis of gestational Diabetes mellitus? Diabetol Int. 2021. https://doi.org/10.1007/s13340-020-00484-0.

Kasteleyn MJ, de Vries L, van Puffelen AL, Schellevis FG, Rijken M, Vos RC, et al. Diabetes-related distress over the course of illness: results from the Diacourse study. Diabet Med. 2015;32(12):1617–24. https://doi.org/10.1111/dme.12743.CrossRefPubMed

Glycemic targets: Standards of medical care in diabetes—2018. Diabetes Care. 2018;41(Supplement 1):S55–64. https://doi.org/10.2337/dc18-S006.

Babaniamansour S, Aliniagerdroudbari E, Niroomand M. Glycemic control and associated factors among Iranian population with type 2 diabetes mellitus: a cross-sectional study. J Diabetes Metab Disord. 2020. https://doi.org/10.1007/s40200-020-00583-4.CrossRefPubMed

Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006;23(11):1165–73. https://doi.org/10.1111/j.1464-5491.2006.01943.x.CrossRefPubMed

10.

Aljuaid MO, Almutairi AM, Assiri MA, Almalki DM, Alswat K. Diabetes-related distress assessment among type 2 diabetes patients. J Diabetes Res. 2018;2018:7328128. https://doi.org/10.1155/2018/7328128.CrossRefPubMedPubMedCentral

11.

Baek RN, Tanenbaum ML, Gonzalez JS. Diabetes burden and diabetes distress: the buffering effect of social support. Ann Behav Med. 2014;48(2):145–55. https://doi.org/10.1007/s12160-013-9585-4.CrossRefPubMedPubMedCentral

12.

Hessler DM, Fisher L, Mullan JT, Glasgow RE, Masharani U. Patient age: a neglected factor when considering disease management in adults with type 2 diabetes. Patient Educ Couns. 2011;85(2):154–9. https://doi.org/10.1016/j.pec.2010.10.030.CrossRefPubMed

13.

Albright TL, Parchman M, Burge SK. Predictors of self-care behavior in adults with type 2 diabetes: an RRNeST study. Fam Med. 2001;33(5):354–60.PubMed

14.

Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med. 2005;22(10):1379–85. https://doi.org/10.1111/j.1464-5491.2005.01644.x.CrossRefPubMed

15.

Chew BH, Vos R, Mohd-Sidik S, Rutten GE. Diabetes-related distress, depression and distress-depression among adults with type 2 diabetes mellitus in Malaysia. PLoS One. 2016;11(3):e0152095. https://doi.org/10.1371/journal.pone.0152095.CrossRefPubMed

16.

Schmitt A, Reimer A, Kulzer B, Haak T, Ehrmann D, Hermanns N. How to assess diabetes distress: Comparison of the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS). Diabet Med. 2015;33. https://doi.org/10.1111/dme.12887.

17.

Pereira A, Oliveira CA, Bártolo A, Monteiro S, Vagos P, Jardim J, Ciência. Reliability and factor structure of the 10-item Kessler Psychological Distress Scale (K10) among Portuguese adults. Saúde Coletiva. 2019;24:729–36. https://doi.org/10.1590/1413-81232018243.06322017.

18.

Watson D, Friend R. Social Avoidance and Distress Scale (SADS). 1969. https://www.statisticssolutions.com/social-avoidance-and-distress-scale-sads/. Accessed 28 June 2020.

19.

Fisher L, Glasgow RE, Mullan JT, Skaff MM, Polonsky WH. Development of a brief diabetes distress screening instrument. Ann Fam Med. 2008;6(3):246–52. https://doi.org/10.1370/afm.842.CrossRefPubMedPubMedCentral

20.

Islam M, Karim MR, Habib SH. Diabetes distress among type 2 diabetic patients. Int J Med Biomed Res. 2013;2:113–24. https://doi.org/10.14194/ijmbr.224.CrossRef

21.

Zhou H, Zhu J, Liu L, Li F, Fish AF, Chen T, et al. Diabetes-related distress and its associated factors among patients with type 2 diabetes mellitus in China. Psychiatry Res. 2017;252:45–50. https://doi.org/10.1016/j.psychres.2017.02.049.CrossRefPubMed

22.

Wong EM, Afshar R, Qian H, Zhang M, Elliott TG, Tang TS. Diabetes distress, depression and glycemic control in a Canadian-based specialty care setting. Can J Diabetes. 2017;41(4):362–5. https://doi.org/10.1016/j.jcjd.2016.11.006.CrossRefPubMed

23.

Huis In ‘T Veld EMJ, Makine C, Nouwen A, Karşıdağ Ç, Kadıoğlu P, Karşıdağ K et al. Validation of the Turkish version of the problem areas in diabetes scale. Cardiovasc Psychiatry Neurol. 2011;2011:315068. https://doi.org/10.1155/2011/315068.

24.

Chew BH, Mukhtar F, Sherina MS, Paimin F, Hassan NH, Jamaludin NK. The reliability and validity of the Malay version 17-item diabetes distress scale. Malays Fam Physician. 2015;10(2):22–35.PubMedPubMedCentral

25.

Onyenekwe BM, Young EE, Nwatu CB, Okafor CI, Ugwueze CV. Diabetes distress and associated factors in patients with diabetes mellitus in South East Nigeria. Dubai Diabetes Endocrinol J. 2020;26(1):31–7. https://doi.org/10.1159/000508706.CrossRef

26.

Ghafari S-M, Shahbazian H, Kholghi M, Haghdoust M. Relationship between social support and depression in diabetic patients. Jundishapur Sci Med J. 2010;8(463):383–9.

27.

Khamseh ME, Baradaran HR, Javanbakht A, Mirghorbani M, Yadollahi Z, Malek M. Comparison of the CES-D and PHQ-9 depression scales in people with type 2 diabetes in Tehran, Iran. BMC Psychiatry. 2011;11(1):61. https://doi.org/10.1186/1471-244X-11-61.

28.

Tajfard M, Mobarhan MG, Rahimi HR, Mouhebati M, Esmaeily H, Ferns GA, et al. Anxiety, depression, coronary artery disease and diabetes mellitus; an association study in Ghaem Hospital, Iran. Iran Red Crescent Med J. 2014;16(9):e14589. https://doi.org/10.5812/ircmj.14589.

29.

Tol A, Baghbanian A, Sharifirad G, Shojaeizadeh D, Eslami A, Alhani F, et al. Assessment of diabetic distress and disease related factors in patients with type 2 diabetes in Isfahan: A way to tailor an effective intervention planning in Isfahan-Iran. J Diabetes Metab Disord. 2012;11(1):20. https://doi.org/10.1186/2251-6581-11-20.CrossRefPubMedPubMedCentral

30.

Baradaran HR, Mirghorbani SM, Javanbakht A, Yadollahi Z, Khamseh ME. Diabetes distress and its association with depression in patients with type 2 diabetes in Iran. Int J Prev Med. 2013;4(5):580–4.PubMedPubMedCentral

31.

Sankar P, Sasikumar P, Medayil R, Jacob R. High prevalence of distress among patients with Type 2 Diabetes (T2DM)—A hospital-based cross-sectional study from South India. Diabetes. 2018;67(Supplement 1):61-LB. https://doi.org/10.2337/db18-61-LB.CrossRef

32.

Roy M, Sengupta N, Sahana PK, Das C, Talukdar P, Baidya A, et al. Type 2 diabetes and influence of diabetes-specific distress on depression. Diabetes Res Clin Pract. 2018;143:194–8. https://doi.org/10.1016/j.diabres.2018.07.006.CrossRefPubMed

33.

Graue M, Haugstvedt A, Wentzel-Larsen T, Iversen MM, Karlsen B, Rokne B. Diabetes-related emotional distress in adults: reliability and validity of the Norwegian versions of the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS). Int J Nurs Stud. 2012;49(2):174–82. https://doi.org/10.1016/j.ijnurstu.2011.08.007.CrossRefPubMed

34.

Nanayakkara N, Pease A, Ranasinha S, Wischer N, Andrikopoulos S, Speight J, et al. Depression and diabetes distress in adults with type 2 diabetes: results from the Australian National Diabetes Audit (ANDA) 2016. Sci Rep. 2018;8(1):7846. https://doi.org/10.1038/s41598-018-26138-5.CrossRefPubMed

35.

Beck AT, Steer RA, Ball R, Ranieri W. Comparison of beck depression inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996;67(3):588–97. https://doi.org/10.1207/s15327752jpa6703_13.CrossRefPubMed

36.

Mocan AS, Iancu SS, Duma L, Mureseanu C, Baban AS. Depression in romanian patients with type 2 diabetes: prevalence and risk factors. Clujul Med (1957). 2016;89(3):371-7. https://doi.org/10.15386/cjmed-641.

37.

Nicolucci A, Kovacs Burns K, Holt RI, Comaschi M, Hermanns N, Ishii H, et al. Diabetes Attitudes, Wishes and Needs second study (DAWN2): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabet Med. 2013;30(7):767–77. https://doi.org/10.1111/dme.12245.CrossRefPubMed

38.

Jannoo Z, Wah YB, Lazim AM, Hassali MA. Examining diabetes distress, medication adherence, diabetes self-care activities, diabetes-specific quality of life and health-related quality of life among type 2 diabetes mellitus patients. J Clin Trans Endocrinol. 2017;9:48–54. https://doi.org/10.1016/j.jcte.2017.07.003.CrossRef

39.

Schmitt A, Gahr A, Hermanns N, Kulzer B, Huber J, Haak T. The Diabetes Self-Management Questionnaire (DSMQ): development and evaluation of an instrument to assess diabetes self-care activities associated with glycaemic control. Health Qual Life Outcomes. 2013;11(1):138. https://doi.org/10.1186/1477-7525-11-138.CrossRefPubMed

40.

Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N. Psychometric properties of a Persian-language version of the Beck Depression Inventory–Second edition: BDI-II-PERSIAN. Depress Anxiety. 2005;21(4):185–92. https://doi.org/10.1002/da.20070.CrossRefPubMed

41.

Garrusi B, Baneshi M, Moradi S. Psychosocial contributing factors that affect mental well being in diabetic patients. Russ Open Med J. 2013;2. https://doi.org/10.15275/rusomj.2013.0106.

42.

Nejaddadgar N, Solhi M, Jegarghosheh S, Abolfathi M, Ashtarian H. Self-care and related factors in patients with type 2 diabetes. Asian J Biomed Pharm Sci. 2017;7(61):6–10.

43.

Honarvar B, Khaksar E, Keshavarz P, Movahednejad Y, Banakar M. Quality of life in the Elders has not been regarded as much as their life span: A population-based study from Iran. Durham: Research Square; 2020. https://doi.org/10.21203/rs.3.rs-19225/v1.

44.

Gariepy G, Smith KJ, Schmitz N. Diabetes distress and neighborhood characteristics in people with type 2 diabetes. J Psychosom Res. 2013;75(2):147–52. https://doi.org/10.1016/j.jpsychores.2013.05.009.CrossRefPubMed

45.

Chin YW, Lai PSM, Chia YC. The validity and reliability of the English version of the diabetes distress scale for type 2 diabetes patients in Malaysia. BMC Fam Pract. 2017;18(1):25. https://doi.org/10.1186/s12875-017-0601-9.CrossRefPubMed

46.

Joensen LE, Tapager I, Willaing I. Diabetes distress in Type 1 diabetes–a new measurement fit for purpose. Diabet Med. 2013;30(9):1132–9. https://doi.org/10.1111/dme.12241.CrossRefPubMed

47.

Martinez-Vega IP, Doubova SV, Aguirre-Hernandez R, Infante-Castañeda C. Adaptation and validation of the distress scale for Mexican patients with type 2 diabetes and hypertension: a cross-sectional survey. BMJ Open. 2016;6(3):e009723. https://doi.org/10.1136/bmjopen-2015-009723.CrossRefPubMedPubMedCentral

48.

Kuniss N, Kramer G, Müller N, Kloos C, Lehmann T, Lorkowski S, et al. Diabetes-related burden and distress is low in people with diabetes at outpatient tertiary care level. Exp Clin Endocrinol Diabetes. 2016;124(5):307–12. https://doi.org/10.1055/s-0042-103685.CrossRefPubMed

49.

Kuniss N, Rechtacek T, Kloos C, Müller UA, Roth J, Burghardt K, et al. Diabetes-related burden and distress in people with diabetes mellitus at primary care level in Germany. Acta Diabetol. 2017;54(5):471–8. https://doi.org/10.1007/s00592-017-0972-3.CrossRefPubMed

50.

Fisher L, Hessler DM, Polonsky WH, Mullan J. When is diabetes distress clinically meaningful? Establishing cut points for the diabetes. Distress Scale. 2012;35(2):259–64. https://doi.org/10.2337/dc11-1572.CrossRef

51.

Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, et al. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005;28(3):626–31. https://doi.org/10.2337/diacare.28.3.626.CrossRefPubMed

52.

Babaniamansour P, Mohammadi M, Babaniamansour S, Aliniagerdroudbari E. The relation between atherosclerosis plaque composition and plaque rupture. J Med Signals Sens. 2020. https://doi.org/10.4103/jmss.JMSS_48_19.CrossRefPubMedPubMedCentral

53.

Perveen S, Otho MS, Siddiqi MN, Hatcher J, Rafique G. Association of depression with newly diagnosed type 2 diabetes among adults aged between 25 to 60 years in Karachi, Pakistan. Diabetol Metab Syndr. 2010;2:17-. https://doi.org/10.1186/1758-5996-2-17.CrossRefPubMed

54.

Yu R, Y-Hua L, Hong L. Depression in newly diagnosed type 2 diabetes. Int J Diabetes Dev Ctries. 2010;30(2):102–4. https://doi.org/10.4103/0973-3930.62601.CrossRefPubMedPubMedCentral

55.

Raval A, Dhanaraj E, Bhansali A, Grover S, Tiwari P. Prevalence and determinants of depression in type 2 diabetes patients in a tertiary care centre. Indian J Med Res. 2010;132:195–200.PubMed

56.

Sotiropoulos A, Papazafiropoulou A, Apostolou O, Kokolaki A, Gikas A, Pappas S. Prevalence of depressive symptoms among non insulin treated Greek type 2 diabetic subjects. BMC Res Notes. 2008;1:101-. https://doi.org/10.1186/1756-0500-1-101.CrossRefPubMed

57.

Khamseh ME, Baradaran HR, Rajabali H. Depression and diabetes in Iranian patients: a comparative study. Int J Psychiatry Med. 2007;37(1):81–6. https://doi.org/10.2190/fp64-82v3-1741-842v.CrossRefPubMed

58.

Bajaj S, Agarwal S, Varma A, Singh V. Association of depression and its relation with complications in newly diagnosed type 2 diabetes. Indian J Endocrinol Metabol. 2012;16(5):759–63. https://doi.org/10.4103/2230-8210.100670.CrossRef

59.

Larijani B, Khoram-Shahi Bayan M, Gorgani MK, Bandarian F, Akhondzadeh S. Association of depression and diabetes in the Doctor Shariati Diabetes Clinic and Lranian Diabetes Association. J Diabetes Metab Disord. 2004.

Title: Distress and depression among patients with diabetes mellitus: prevalence and associated factors: a cross‐sectional study
Authors: Mahtab Niroomand
Sepideh Babaniamansour
Ehsan Aliniagerdroudbari
Ali Golshaian
Azadeh Mazaheri Meibodi
Abdorrahim Absalan
Publication date: 01-06-2021
Publisher: Springer International Publishing
Keywords: Affective Disorder
Care
Affective Disorder
Diabetes
Published in: Journal of Diabetes & Metabolic Disorders / Issue 1/2021
Electronic ISSN: 2251-6581
DOI: https://doi.org/10.1007/s40200-020-00721-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Distress and depression among patients with diabetes mellitus: prevalence and associated factors: a cross‐sectional study

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Mass spectrometry with derivatization method for concurrent measurement of amino acids and acylcarnitines in plasma of diabetic type 2 patients with diabetic nephropathy

Minocycline alleviates nociceptive response through modulating the expression of NR2B subunit of NMDA receptor in spinal cord of rat model of painful diabetic neuropathy

Effect of 532 nm argon laser pan retinal photocoagulation on corneal thickness and corneal endothelial cell parameters among proliferative diabetic retinopathy patients

Synergistic effect of micronutrients and metformin in alleviating diabetic nephropathy and cardiovascular Dysfunctioning in diabetic rat

The effect of spirulina on type 2 diabetes: a systematic review and meta-analysis

Vitamin D Receptor gene polymorphisms and susceptibility to type 2 diabetes: evidence from a meta-regression and meta-analysis based on 47 studies

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page